JPS633846B2 - - Google Patents

Info

Publication number
JPS633846B2
JPS633846B2 JP54014568A JP1456879A JPS633846B2 JP S633846 B2 JPS633846 B2 JP S633846B2 JP 54014568 A JP54014568 A JP 54014568A JP 1456879 A JP1456879 A JP 1456879A JP S633846 B2 JPS633846 B2 JP S633846B2
Authority
JP
Japan
Prior art keywords
hydroxyamino
antibacterial agent
formyl
monosodium salt
phosphonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54014568A
Other languages
English (en)
Japanese (ja)
Other versions
JPS54147933A (en
Inventor
Hiroshi Imanaka
Minoru Nishida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/877,944 external-priority patent/US4196193A/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS54147933A publication Critical patent/JPS54147933A/ja
Priority to US06/192,437 priority Critical patent/US4330529A/en
Publication of JPS633846B2 publication Critical patent/JPS633846B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP1456879A 1978-02-15 1979-02-09 Anti-microbial agent Granted JPS54147933A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US06/192,437 US4330529A (en) 1978-02-15 1980-09-29 Antibacterial composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/877,944 US4196193A (en) 1978-02-15 1978-02-15 Antibacterial composition
US05/942,364 US4210635A (en) 1978-02-15 1978-09-14 Antibacterial composition

Publications (2)

Publication Number Publication Date
JPS54147933A JPS54147933A (en) 1979-11-19
JPS633846B2 true JPS633846B2 (ref) 1988-01-26

Family

ID=27128465

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1456879A Granted JPS54147933A (en) 1978-02-15 1979-02-09 Anti-microbial agent

Country Status (4)

Country Link
US (1) US4210635A (ref)
EP (1) EP0003618B1 (ref)
JP (1) JPS54147933A (ref)
DE (1) DE2960091D1 (ref)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268503A (en) * 1978-09-14 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
FI802964A7 (fi) * 1979-09-28 1981-03-28 F Hoffmann La Roche & Co Vaikutusaineyhdistelmä ja niiden valmistus.
JPS56128714A (en) * 1980-03-07 1981-10-08 Intaretsukusu Research Corp Oral absorption-improved beta-lactam antibiotic oral dosage
JP4727854B2 (ja) * 2001-07-26 2011-07-20 ヤンマー株式会社 移動農機
PE20150199A1 (es) 2012-06-29 2015-01-31 Bayer Animal Health Gmbh Composiciones farmaceuticas y tratamiento de mastitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH13967A (en) * 1976-07-27 1980-11-12 Fujisawa Pharmaceutical Co Antibiotics phosphonic acid derivatives and production and use thereof
GB1580899A (en) * 1976-07-27 1980-12-10 Fujisawa Pharmaceutical Co Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof

Also Published As

Publication number Publication date
US4210635A (en) 1980-07-01
DE2960091D1 (en) 1981-03-19
EP0003618A1 (en) 1979-08-22
JPS54147933A (en) 1979-11-19
EP0003618B1 (en) 1981-01-28

Similar Documents

Publication Publication Date Title
RU2569059C2 (ru) Фармацевтические композиции, содержащие бета-лактамный антибиотик, сульбактам и ингибитор бета-лактамаз
EA003458B1 (ru) Усиление активности оксазолидиноновых антибактериальных агентов в результате применения производных аргинина
RU2524665C2 (ru) Композиции и способы лечения, включающие цефтаролин
JPH08505868A (ja) クラブラン酸のみまたは他のベータ−ラクタム抗生物質と混合されたクラブラン酸からなる薬剤処方
US4268503A (en) Antibacterial composition
JPS6312043B2 (ref)
JPS633846B2 (ref)
EP0544760B1 (en) Pharmaceutical compositions containing 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyl) methylsulfinyl] benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders
EP2167081B1 (en) Bactericidal anti-mrsa active pharmaceutical composition containing carbapenems
US4330529A (en) Antibacterial composition
US4199566A (en) Antibacterial composition for medical use
US4610993A (en) Use of selected pyridine-N-oxide disulfide compounds to treat or prevent bovine mastitis
US4196193A (en) Antibacterial composition
US4092411A (en) Antibacterial composition
US4534968A (en) Pharmaceutical compositions
US4428936A (en) Antibacterial composition for medical use
JPS6326732B2 (ref)
Spurlock et al. Antibiotics in the treatment of wounds
JPS634526B2 (ref)
Records Subconjunctival injection of the repository penicillins: A comparative study of the intraocular penetration
JP6626516B2 (ja) 抗菌組成物及び方法
EP0607122B1 (en) Veterinary treatment
Muggleton Why Cefuroxime?
KR100190869B1 (ko) 아목시실린 및 클라부란산을 포함하여 구성되는 수의학적 조성물 및 그를 사용한 치료방법
RU2424801C1 (ru) Средство для лечения инфекционных болезней